Overview

Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of KWA-0711, and to determine its optimal dose in Chronic Constipation (CC) patients.

Phase:

Phase 2

Details

Lead Sponsor:

Kissei Pharmaceutical Co., Ltd.